Compound information
- Natural Products
- ZC2419001
- Molecular Formula
- C14H11ClFNO2
- Molecular Weight
- 279.046234492 g/mol
- Structure
-
- IUPAC Name
- benzyl N-(4-chloro-3-fluoro-phenyl)carbamate
- InChI
- InChI=1S/C14H11ClFNO2/c15-12-7-6-11(8-13(12)16)17-14(18)19-9-10-4-2-1-3-5-10/h1-8H,9H2,(H,17,18)
- InChI Key
- GWQRRBZEWJDIGO-UHFFFAOYSA-N
- SMILES
- O=C(Nc1ccc(Cl)c(F)c1)OCc1ccccc1
- Source
- ZINC000261493676
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 19 | Ring Count | 2 |
Heteroatom Count | 5 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 38.33 Å2 | LogP | 4.218 |
LogS | -4.675 | LogD | 3.677 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.639 | Pgp substrate | 0.004 |
HIA | 0.962 | F20 % | 0.994 |
F30 % | 0.933 | Caco-2 | -4.538 |
MDCK | -4.567 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.611 | PPB | 99.939 |
VD | 0.541 | Fu | 1.841 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 1.0 | CYP1A2 substrate | 0.855 |
CYP2A6 substrate | 0.812 | CYP2B6 substrate | 0.746 |
CYP2C19 inhibitor | 0.986 | CYP2C19 substrate | 0.939 |
CYP2C8 substrate | 0.923 | CYP2C9 inhibitor | 0.831 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.975 |
CYP2D6 substrate | 0.959 | CYP2E1 substrate | 0.954 |
CYP3A4 inhibitor | 0.171 | CYP3A4 substrate | 0.981 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.347 | CL | 10.405 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.008 | Hepatotoxicity | 0.989 |
Mutagenicity | 0.654 | Rat Oral Acute Toxicity | 0.028 |
FDAMDD | 0.692 | Skin Sensitization | 0.673 |
Carcinogenicity | 0.119 | Eye Corrosion | 0.004 |
Eye Irritation | 0.009 | Respiratory Toxicity | 0.323 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 2.451 | IGC50 | 4.318 |
LC50FM | 5.1 | LC50DM | 7.345 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.255 | NR-AR-LBD | 0.221 |
NR-AhR | 0.879 | NR-Aromatase | 0.131 |
NR-ER | 0.804 | NR-ER-LBD | 0.46 |
NR-PPAR-gamma | 0.579 | SR-ARE | 0.677 |
SR-ATAD5 | 0.694 | SR-HSE | 0.307 |
SR-MMP | 0.912 | SR-p53 | 0.67 |
Similar covalent drugs
No similar covalent drugs found for this compound.